Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Luye Pharma Prices Hong Kong IPO at Top of Range | July 7, 2014
Fosun Terminates $531 Million Out-licensing Deal with Sellas | July 2, 2014
Luye Pharma to Stage $764 Million IPO in Hong Kong | June 23, 2014
JHL Biotech Raises $35 Million to Fund Drug Development | June 19, 2014
BGI Sells Stake in Prenatal Testing Subsidiary for $320 Million | June 11, 2014
Fosun and Sinopharm Form $1 Billion Drug Distribution JV | June 6, 2014
ChinaBio in the News
More events coming soon...